HLA-DRB1(∗)0401 and HLA-DRB1(∗)0408 Are Strongly Associated with the Development of Antibodies against Interferon-β Therapy in Multiple Sclerosis

The formation of antibodies to interferon-beta (IFN-β), a protein-based disease-modifying agent for multiple sclerosis (MS), is a problem in clinical practice. These antibodies may neutralize the biological effects of the protein drug, potentially decreasing its therapeutic effects. By high-resoluti...

وصف كامل

محفوظ في:
التفاصيل البيبلوغرافية
المؤلفون الرئيسيون: Hoffmann, Steve, Cepok, Sabine, Grummel, Verena, Lehmann-Horn, Klaus, Hackermueller, Jörg, Stadler, Peter F., Hartung, Hans-Peter, Berthele, Achim, Deisenhammer, Florian, Wasmuth, Ralf, Hemmer, Bernhard
التنسيق: Artigo
اللغة:Inglês
منشور في: Elsevier 2008
الموضوعات:
Article
الوصول للمادة أونلاين:https://ncbi.nlm.nih.gov/pmc/articles/PMC2495071/
https://ncbi.nlm.nih.gov/pubmed/18656179
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ajhg.2008.07.006
الوسوم: إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!

مواد مشابهة